CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$2.47
Tradestie Score
32
Market Cap
$149.66M
P/E Ratio
6.5
Revenue Growth
1.1%
Analyst Upside
+86.2%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VOR
Vor Biopharma Inc. Common Stock
|
$22.30
|
$269.08M | 0.1 | 47 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.21
|
$262.67M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$35.48
|
$256.54M | - | 43 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$13.02
|
$240.89M | - | 55 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.07
|
$231.77M | - | 42 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.88
|
$227.00M | - | 47 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.55
|
$211.22M | - | 49 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.32
|
$202.58M | - | 49 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$19.41
|
$199.71M | - | 31 | Compare |
More CGEN Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2836)
239 stocks in this industry